Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Generic Pharmaceutical Association (GPhA) - Senior Advisors to Presidential Candidates John McCain and Barack Obama Affirm Support for Increased Access to Generic Medicines and Creation of an FDA Approval Pathway for Biogenerics
Hoana Medical, Inc. - Hoana Medical Acquires CAN ISO and J-GMP Marks to Expand Patient Safety Technology to Canadian and Asian Market
Pfizer Inc - Pfizer Launches New Medicine Safety Website to Help Healthcare Professionals and Patients Make Better Informed Decisions about Treatment Options
Adverse Drug Reactions - Investigators at Federal Institute for Drugs and Medical Devices have published new data on adverse drug reactions
American Chemistry Council - New Bisphenol a Study Has Limited Capability to Assess Human Health Effects
Anthrax - Research reports from Food & Drug Administration provide new insights into anthrax
Anthrax Vaccines - PharmAthene Response to DHHS Request for Proposals for Recombinant Protective Antigen Anthrax Vaccine Deemed Technically Acceptable and Within Competitive Range for Procurement Consideration
Chronic Disease Gene Therapy - Researchers at University of Louisville, Department of Medicine target chronic disease gene therapy
Clinical Trial Research - Research on clinical trial research published by scientists at Hokuriku University, Faculty of Pharmaceutical Sciences
Clinical Trial Research - SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
Colon Cancer - New findings from K.S. Lovejoy and co-authors in the area of colon cancer published
CV Technologies Inc. - Colds and flu cut by one-third in study of Canada's top cold fighter in vaccinated seniors
Dengue Fever - Research from B.K.W. Koh and co-researchers in the area of dengue fever published
Drug Resistance - Reports from University of Buenos Aires highlight recent research in drug resistance
Emergent BioSolutions Inc. - Emergent BioSolutions Notified by HHS That Its Proposal to Provide 25 Million Doses of Its Recombinant Anthrax Vaccine Is Technically Acceptable and Within the Competitive Range
Encephalitis - New findings from L.E. Davis and co-authors describe advances in encephalitis
Enjoy Life Foods - Enjoy Life Foods CEO Tells FDA Grocery Stores Remain a Dangerous Minefield for Food Allergic, Food Intolerant and Celiac Shoppers
Escherichia Coli - Findings from University of Idaho broaden understanding of Escherichia coli
Escherichia Coli - Study findings from Purdue University provide new insights into Escherichia coli
Gilead Sciences, Inc. - Gilead Receives Complete Response Letter from U.S. Food and Drug Administration for Aztreonam Lysine for Inhalation, an Investigational Treatment for Cystic Fibrosis
Glaucoma - SOLX Receives FDA 510(k) Clearance for New Glaucoma Laser
Heart Failure - Study data from S.G. Weeks and co-authors update knowledge of heart failure
Homeopathy - New homeopathy study findings recently were reported by E.A. Thompson and co-researchers
Hypertension - Daiichi Sankyo, Inc. Files Supplemental New Drug Application for AZOR(R) as Initial Therapy for High Blood Pressure
InNexus Biotechnology Inc. - InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
Intact Medical Corporation - Intact Medical Corporation's Intact(R) Excise XL Receives 510(K) Marketing Clearance from the FDA
NPS Pharmaceuticals, Inc. - Positive Interim Data from Phase 2 Study of NPSP558 Parathyroid Hormone 1-84 for Hypoparathyroidism Reported at ASBMR Annual Meeting
Nuvo Research Inc. - Nuvo announces Debenture holders agree to resolution
Orthovita, Inc. - Orthovita Files Response to FDA's Initial Review of the CORTOSS 510k Application
Osteoarthritis - NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
OVATION Pharmaceuticals, Inc. - OVATION Pharmaceuticals Acquires Rights to Commercialize Xenazine Tetrabenazine in U.S. for Chorea Associated with Huntington's Disease
Pancreas Transplants - Reports summarize pancreas transplants research from G. Santori and co-authors
Pharmacology - ChanTest to Highlight its World-Leading Ion Channel Safety Services and Largest Catalog of Ion Channel-Expressing Cell Lines at Safety Pharmacology Society, Booth 702
Pharmacology - New pharmacology study results from Food & Drug Administration described
Plague - Recent findings in plague described by L. Vitagliano and colleagues
Plague Immunology - New plague immunology study findings recently were reported by S. Ayyadurai and co-researchers
Psychiatry - Online Tool That Generates Fictitious Psychiatric Disorders Achieves Five Million Views Mark: NaturalNews.com
Public Health - Collaborative Software Initiative Releases Citizen-Centric Public Health Application and Community
Public Health - Researchers from Thammasat University, Faculty of Public Health report recent findings in public health
Ranbaxy Laboratories, Ltd. - Ranbaxy Laboratories, Ltd., Retains Former New York City Mayor Rudy Giuliani to Lead Team in Resolution of Issues Raised by U. S. Food & Drug Administration
Regulatory Actions - Mylan Receives FDA Approval for Generic Version of Anti-Psychotic Risperdal(R)
Regulatory Actions - Study results from C.I. Starner and colleagues update understanding of regulatory actions
Restless Legs Syndrome - GSK and XenoPort Announce Submission of New Drug Application Requesting FDA Approval of Solzira(TM) for Restless Legs Syndrome
Sciele Pharma, Inc. - Sciele Completes Pivotal Phase III Program for Glycopyrrolate in Pediatric Patients with Chronic, Moderate-to-Severe Drooling
